2020
DOI: 10.32383/appdr/122393
|View full text |Cite
|
Sign up to set email alerts
|

The Pharmacotherapy Time-to-Effect of Overactive Bladder Medications and Treatment Duration

Abstract: For Overactive Bladder (OAB) treatment, pharmacotherapy is currently deemed as a second option. However, in the current publications related to OAB, there is a significant research gap concerning the time-toeffect and duration of OAB pharmacotherapy. Such data is vital for effective and successful treatment of OAB, and hence, the study aimed to find information in this gap to assist healthcare providers in their daily activities in treating OAB. The study utilized the Web of Science databases, MEDLINE, Cochran… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 40 publications
0
1
0
Order By: Relevance
“…OAB is a symptom-syndrome, and treatment focuses mainly on mitigating symptoms [28]. OAB treatment compliance is an issue in routine clinical practice.…”
Section: Discussionmentioning
confidence: 99%
“…OAB is a symptom-syndrome, and treatment focuses mainly on mitigating symptoms [28]. OAB treatment compliance is an issue in routine clinical practice.…”
Section: Discussionmentioning
confidence: 99%